Erythromycin Export Market Intelligence: India's 368 Suppliers Shipping to 135 Countries — TransData Nexus 2026

Q: Who are the top erythromycin exporters from India?

The top erythromycin exporters from India are: 1. MEDOPHARM — $25.5M (32.0% market share); 2. BDH INDUSTRIES LIMITED — $5.7M (7.1% market share); 3. LINCOLN PHARMACEUTICALS LTD — $2.9M (3.6% market share); 4. S KANT HEALTHCARE LIMITED — $2.8M (3.5% market share); 5. MEDREICH LIMITED — $2.1M (2.7% market share). Together they account for 48.9% of India's total erythromycin export value.

Q: What is the total export value of erythromycin from India?

The total export value of erythromycin from India is $79.7M USD, recorded across 3,939 shipment transactions from 368 active exporters to 135 destination countries. The average shipment value is $20.2K.

Q: Which countries import erythromycin from India?

India exports erythromycin to 135 countries worldwide. The top importing countries are: AFGHANISTAN (28.8% share, $22.9M), PHILIPPINES (14.3% share, $11.4M), MOZAMBIQUE (7.0% share, $5.6M), NIGERIA (6.0% share, $4.7M), TANZANIA (3.9% share, $3.1M). These five markets account for 59.9% of total export value.

Q: What is the HS code for erythromycin exports from India?

The primary HS code for erythromycin exports from India is 30042061. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of erythromycin exports from India?

The average unit price for erythromycin exports from India is $92.64 USD per unit, with prices ranging from $0.01 to $89112.90 depending on formulation, packaging, and order volume. The total market is valued at $79.7M across 3,939 shipments.

Q: Which ports handle erythromycin exports from India?

The primary ports for erythromycin exports from India are SAHAR AIR CARGO ACC (INBOM4) (13.0% of shipments), DELHI AIR CARGO ACC (INDEL4) (10.0% of shipments), SAHAR AIR (9.6% of shipments), NHAVA SHEVA SEA (INNSA1) (9.4% of shipments), JNPT/ NHAVA SHEVA SEA (5.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of erythromycin?

India is one of the world's leading exporters of erythromycin due to its large base of 368 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports erythromycin to 135 countries, demonstrating 69% global market coverage.

Q: What certifications do Indian erythromycin exporters need?

Indian erythromycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import erythromycin from India?

There are 992 registered buyers importing erythromycin from India, spread across 135 countries. The repeat buyer rate is 45.9%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top erythromycin supplier from India?

MEDOPHARM is the leading erythromycin exporter from India with a market share of 32.0% and total export value of $25.5M across 61 shipments. The top 5 suppliers together control 48.9% of total export value.

Suresh Sormare

Erythromycin

India Pharmaceutical Trade Intelligence

$79.7M368 Suppliers135 CountriesHS 30042061

ExportsIndia → AFGHANISTAN28.8%India → PHILIPPINES14.3%

ImportsBULGARIA → India$3.6M UNITED STATES → India$337.8K

#1 Supplier: MEDOPHARM

Erythromycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Erythromycin to the World

Between 2022 and 2026, India exported $79.7M worth of erythromycin across 3,939 verified shipments to 135 countries — covering 69% of world markets in the Antibiotics segment. The largest destination is AFGHANISTAN (28.8%). MEDOPHARM leads with a 32.0% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30042061

Erythromycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Erythromycin export data snapshot — $79.7M · 368 exporters · 135 countriesTransData Nexus · Indian Customs Data

Top Erythromycin Exporters from India

368 active exporters · Ranked by export value

View all 368 →

Top Erythromycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MEDOPHARM	$25.5M	61	14	32.0%
2	BDH INDUSTRIES LIMITED

Top Countries Importing Erythromycin from India

135 destination markets · Ranked by import value

All 135 countries →

Top Countries Importing Erythromycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	AFGHANISTAN	$22.9M	28.8%
2	PHILIPPINES	$11.4M	14.3%
3	MOZAMBIQUE	$5.6M	7.0%
4	NIGERIA	$4.7M	6.0%
5	TANZANIA	$3.1M	3.9%
6	UNITED STATES	$2.2M	2.7%
7	UNITED KINGDOM	$1.7M	2.1%
8	LIBERIA	$1.5M	1.9%
9	CAMEROON	$1.4M	1.8%
10	RWANDA	$1.3M	1.7%

AFGHANISTAN is India's largest erythromycin export destination, absorbing 28.8% of total exports worth $22.9M. The top 5 importing countries — AFGHANISTAN, PHILIPPINES, MOZAMBIQUE, NIGERIA, TANZANIA — together account for 59.9% of India's total erythromycin export value. The remaining 130 destination countries collectively receive the other 40.1%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Erythromycin to India?

6 origin countries · Total import value: $3.9M

India imports erythromycin from 6 countries with a combined import value of $3.9M. The largest supplier is BULGARIA ($3.6M, 4 shipments), followed by UNITED STATES and CANADA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Erythromycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	BULGARIA	$3.6M	4	91.0%
2	UNITED STATES	$337.8K	60	8.6%
3	CANADA	$15.7K	5	0.4%
4	UNITED KINGDOM	$2.2K	13	0.1%
5	BANGLADESH	$180	4	0.0%
6	GAMBIA	$1	1	0.0%

BULGARIA is the largest supplier of erythromycin to India, accounting for 91.0% of total import value. The top 5 origin countries — BULGARIA, UNITED STATES, CANADA, UNITED KINGDOM, BANGLADESH — together supply 100.0% of India's erythromycin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Erythromycin — Export Intelligence Video

Visual overview of India's erythromycin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's erythromycin pharmaceutical import and export market — $79.7M in total trade, 368 verified manufacturers, and 135 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Erythromycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Erythromycin has a longstanding presence in the U.S. market, with multiple approved Abbreviated New Drug Applications (ANDAs). For instance, the FDA approved a generic version of Eryc (erythromycin delayed-release capsules) by Pharmobedient on December 22, 1986. Similarly, a generic version of Erythrocin (erythromycin lactobionate for injection) was approved for Hospira on October 31, 1986. These approvals indicate a well-established regulatory pathway for erythromycin products in the U.S. Given the presence of 368 active Indian exporters, it is crucial for these entities to ensure compliance with FDA regulations, including adherence to current Good Manufacturing Practices (cGMP) and maintaining up-to-date Drug Master Files (DMFs).

2EU & UK Regulatory Framework

In the European Union, erythromycin is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). A notable regulatory action includes the Periodic Safety Update Report Single Assessment (PSUSA) for erythromycin (systemic use), identified as PSUSA/00010808/202203, with conclusions published on January 10, 2023. This assessment underscores the importance of ongoing pharmacovigilance and compliance with EU Good Manufacturing Practice (GMP) standards for Indian exporters targeting the EU market.

3WHO Essential Medicines & Global Standards

Erythromycin is listed in the 24th edition of the WHO Model List of Essential Medicines, published on September 5, 2025. This inclusion highlights its critical role in treating priority health conditions globally. The WHO Model List serves as a guide for countries to develop and update their national essential medicines lists, ensuring the availability of effective and safe medicines. Additionally, erythromycin is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), reflecting its established quality standards.

4India Regulatory Classification

In India, erythromycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, specific ceiling prices for erythromycin should be verified with the latest NPPA notifications. For exports, Indian pharmaceutical companies must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

The primary patents for erythromycin have long expired, allowing for robust generic competition. This competitive landscape is evident from the numerous generic versions approved by regulatory agencies worldwide, including the FDA and EMA. Indian exporters benefit from this scenario, as they can produce and export erythromycin without infringing on active patents, provided they adhere to the regulatory requirements of the importing countries.

6Recent Industry Developments

In February 2026, the UK Veterinary Medicines Directorate (VMD) released data indicating a significant decline in erythromycin sales for veterinary use, with the last reported sales in 2017. This trend may influence the demand for erythromycin in veterinary applications. Additionally, the WHO published the 24th edition of the Model List of Essential Medicines in September 2025, reaffirming erythromycin's status as an essential medicine. These developments underscore the importance of staying informed about regulatory changes and market dynamics to maintain a competitive edge in the global pharmaceutical industry.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Erythromycin

Retail & reference prices across 9 markets vs. India FOB export price of $92.64/unit

Global Price Benchmark for Erythromycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$8.96	USD	According to data from 2015, the price of Erythromycin 500mg tablets in the U.S. increased to $8.96 per tablet.
United Kingdom	$0.50	GBP	As per the British National Formulary (BNF), the price for 100 tablets was £36.40, equating to £0.364 per tablet.
Germany	Data not available	EUR	Specific pricing data for Germany is not available from the provided sources.
Australia	Data not available

Supply Chain Risk Assessment — Erythromycin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Erythromycin, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of India's API and KSM requirements are sourced from China, creating a significant supply chain vulnerability. This dependency exposes the industry to risks associated with geopolitical tensions, trade disputes, and potential disruptions in the supply chain.

To mitigate these risks, the Indian government has implemented the Production Linked Incentive (PLI) Scheme for Bulk Drugs, aiming to promote domestic manufacturing of critical KSMs, DIs, and APIs. As of September 2025, the scheme has led to the establishment of manufacturing capacities for 26 KSMs and APIs, resulting in cumulative sales of ₹2,315 crore and avoiding imports worth ₹1,807 crore. Despite these efforts, the transition to self-reliance is ongoing, and the industry remains susceptible to external supply chain disruptions.

2Supplier Concentration & Single-Source Risk

The export market for Erythromycin from India is notably concentrated, with the top five exporters accounting for 48.9% of total exports. MEDOPHARM leads with a 32.0% share, followed by BDH INDUSTRIES LIMITED (7.1%), LINCOLN PHARMACEUTICALS LTD (3.6%), S KANT HEALTHCARE LIMITED (3.5%), and MEDREICH LIMITED (2.7%). This concentration poses a single-source risk, as disruptions affecting these key players could significantly impact the global supply of Erythromycin.

Access Complete Erythromycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,939 transactions across 135 markets.

Request Demo View Pricing

Frequently Asked Questions — Erythromycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top erythromycin exporters from India?

The leading erythromycin exporters from India are MEDOPHARM, BDH INDUSTRIES LIMITED, LINCOLN PHARMACEUTICALS LTD, and 11 others. MEDOPHARM leads with 32.0% market share ($25.5M). The top 5 suppliers together control 48.9% of total export value.

What is the total export value of erythromycin from India?

The total export value of erythromycin from India is $79.7M, recorded across 3,939 shipments from 368 active exporters to 135 countries. The average shipment value is $20.2K.

Which countries import erythromycin from India?

India exports erythromycin to 135 countries. The top importing countries are AFGHANISTAN (28.8%), PHILIPPINES (14.3%), MOZAMBIQUE (7.0%), NIGERIA (6.0%), TANZANIA (3.9%), which together account for 59.9% of total export value.

What is the HS code for erythromycin exports from India?

The primary HS code for erythromycin exports from India is 30042061. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Erythromycin

Erythromycin

Top Erythromycin Exporters from India

Top Countries Importing Erythromycin from India

Who Supplies Erythromycin to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Erythromycin — Export Intelligence Video

Regulatory Landscape — Erythromycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Erythromycin

Supply Chain Risk Assessment — Erythromycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Erythromycin Trade Intelligence

Frequently Asked Questions — Erythromycin Exports from India

Who are the top erythromycin exporters from India?

What is the total export value of erythromycin from India?

Which countries import erythromycin from India?

What is the HS code for erythromycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of erythromycin exports from India?

Which ports handle erythromycin exports from India?

Why is India a leading exporter of erythromycin?

What certifications do Indian erythromycin exporters need?

How many buyers import erythromycin from India?

What is the market share of the top erythromycin exporter from India?

Analysis Methodology